-
n this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
A prospective observational study was conducted to assess diagnostic and therapeutic efficacies of a daily routine CXR and to evaluate the impact of discontinuing this practice. The setting was a 10-bed mixed medical-surgical ICU of a non-academic teaching hospital in The Netherlands.
-
Most of the attention on catheter-related bloodstream infections (CR-BSI) in the ICU focuses on central venous catheters (CVC), a bias that likely derives, in part, from the 2002 Centers for Disease Control guidelines which stipulate that arterial catheters (AC) have "low infection ratesrarely associated with bloodstream infections.
-
-
Exposures to toxic alcohols such as methanol, ethylene glycol, and isopropanol have been reported in the medical literature for decades. These agents are found in a variety of household products, leading to accidental ingestion in the pediatric population and intentional ingestion in the adult population as a suicidal agent or as an inexpensive substitute for ethanol.
-
Three criteria identify women who would benefit from empiric antibiotics for cystitis.
-
The FDA has approved another beta-adrenergic blocker.
-
Testosterone in Older Men: Is Low Normal Too Low?, CT Pulmonary Angiography as Good as Ventilation- perfusion Scanning for Suspected Pulmonary Embolus, Vertebral Fracture Begets Vertebral Fractureand
-
The 12-lead ECG and lead II rhythm strip in the Figure were obtained from a 59-year old man several days after coronary bypass. He complained of postitional chest pain. How would you interpret his ECG given this clinical context?
-
Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
